The Rx Research Corner is a blog written by the Research Team at PCMA. This blog will take a closer look at complex data and new research findings. Topics cover the PBM and prescription drug space and range from pricing, to policies, and to patient issues such as access and equity.
Generic Drugs Are an American Success Story, Here’s Why
Thanks to PBMs’ efforts to give patients an incentive to use them and pharmacies an incentive to purchase them at the lowest prices, generics are widely available and affordable for hundreds of millions of Americans.
Fun with (Medicare) Stars: Medication Adherence in Beneficiaries with Hypertension
Using data from CMS, we see increases in the average plan contract-level beneficiary adherence to hypertension medication. Gains in adherence translates to real people staying on their medications and having better health outcomes.
Introducing our New Blog Series: Fun with (Medicare) Stars
This blog introduces a new series of blog posts that will look at interesting trends using the CMS’s historical Part D Star Ratings data, focusing on four measures of prescription drug adherence.
CBO Report on Prescription Drug Trends
New report from the Congressional Budget Office highlights the value of PBMs in keeping net drug costs low for payers and patients.
PBM Technology and Expertise Improves Patient Health Outcomes
Pharmacy Benefit Managers reduce prescription drug costs for patients and use innovative technology to help patients get their prescriptions and lead healthier lives.
Orphan Drugs Sound Small but Can Lead to Big Drug Spending
High spending on prescription drugs with both orphan and non-orphan indications suggest potential misuse of Orphan Drug Act designations.
